Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trials data breached
- Novo Nordisk cyberattack exposed pseudonymized clinical trial patient data (IDs, biomarkers, lifestyle factors)
- Company insists no direct PII was leaked, reducing immediate risk of phishing or identity misuse
- Systems shut down for containment; third‑party experts investigating, core operations remain unaffected
Novo Nordisk, one of the biggest pharmaceutical companies in the world, has confirmed it recently suffered a cyberattack in which it lost sensitive data belonging to clinical trials patients.
The company claims the data is pseudonymized and as such cannot be used in phishing scams or other follow-up attacks.
It then said the incident affected a “limited amount” of information related to patients that participated in some of its clinical trials. Since personally identifiable information, such as names or addresses, was not exposed, Novo Nordisk said it doesn’t think the participants could be identified in any way.
Shutting the network down
In a public announcement published on its website...
Copyright of this story solely belongs to techradar.com. To see the full text click HERE
